As the TCGA datasets represent only bulk mRNA from cancer, stromal and immune cells, additional parameters such as immune and stromal cell signatures could be used to stratify the TCGA study cohorts and evaluate the predictive potential of NLRC5 expression in cancer subsets. The gene discussed is NLRC5; the disease is cancer.